惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Hugging Face - Blog
Hugging Face - Blog
Vercel News
Vercel News
C
Check Point Blog
G
Google Developers Blog
博客园 - 司徒正美
量子位
Engineering at Meta
Engineering at Meta
S
SegmentFault 最新的问题
Google DeepMind News
Google DeepMind News
F
Fortinet All Blogs
A
About on SuperTechFans
美团技术团队
D
DataBreaches.Net
Stack Overflow Blog
Stack Overflow Blog
Jina AI
Jina AI
Y
Y Combinator Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
Apple Machine Learning Research
Apple Machine Learning Research
J
Java Code Geeks
MongoDB | Blog
MongoDB | Blog
人人都是产品经理
人人都是产品经理
H
Hackread – Cybersecurity News, Data Breaches, AI and More
The Cloudflare Blog
U
Unit 42

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
COMPASS Pathways plc (CMPS) Q1 2026 Earnings Call Transcript
2026-05-14 · via All Articles on Seeking Alpha

Q1: 2026-05-13 Earnings Summary

EPS of -$0.31 beats by $0.01

 | 

Revenue of

$0.00

beats by $0.00

COMPASS Pathways plc (CMPS) Q1 2026 Earnings Call May 13, 2026 8:00 AM EDT

Company Participants

Stephen Schultz - Senior Vice President of Investor Relations
Kabir Nath - CEO & Director
Lori Englebert - Chief Commercial Officer
Steve Levine - Chief Patient Officer

Conference Call Participants

Lin Tsai - Jefferies LLC, Research Division
François Brisebois - LifeSci Capital, LLC, Research Division
Julian Pino - Stifel, Nicolaus & Company, Incorporated, Research Division
Joshua Schimmer - Cantor Fitzgerald & Co., Research Division
Judah Frommer - Morgan Stanley, Research Division
Ritu Baral - TD Cowen, Research Division
Madison Wynne El-Saadi - B. Riley Securities, Inc., Research Division
Patrick Trucchio - H.C. Wainwright & Co, LLC, Research Division
Leonid Timashev - RBC Capital Markets, Research Division
Sumant Kulkarni - Canaccord Genuity Corp., Research Division
Jinnie Kim - BTIG, LLC, Research Division
Jay Olson - Oppenheimer & Co. Inc., Research Division

Presentation

Operator

Good day, ladies and gentlemen, and welcome to the COMPASS Pathways First Quarter Results Conference Call.

[Operator Instructions] As a reminder, this call is being recorded. I would now like to turn -- to introduce to you your host for today's call, Stephen Schultz. You may begin.

Stephen Schultz
Senior Vice President of Investor Relations

Welcome, all of you, and thank you for joining us today for this conference call. I'm Steve Schultz, Senior Vice President of Investor Relations at COMPASS Pathways. And today, I'm joined by Kabir Nath, our Chief Executive Officer; and Lori Englebert, our Chief Commercial Officer. Teri Loxam, our Chief Financial Officer; and Dr. Steve Levine, our Chief Patient Officer, will be available for the Q&A. The call is being recorded and will be available on the COMPASS Pathways Investor Relations website shortly after the conclusion of the call and will be available for a period of 30 days.

Before we begin, let me remind everyone that during the call today, we